Agios Pharmaceuticals (NASDAQ:AGIO) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Agios Pharmaceuticals beat estimated earnings by 13.53%, reporting an EPS of $-1.47 versus an estimate of $-1.7.
Revenue was up $4.78 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 3.65% drop in the share price the next day.
Here’s a look at Agios Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.62 | -1.76 | -1.75 | -1.81 |
| EPS Actual | -1.66 | -1.49 | -1.68 | -1.74 |
| Revenue Estimate | 4.53M | 5.24M | 2.42M | 2.71M |
| Revenue Actual | 4.31M | 3.52M | 5.58M | 832K |
To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
